|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 0.7060 SEK | +0.86% |
|
-9.95% | -63.04% |
| 08-19 | Enorama Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-19 | Calendar Wednesday, August 19 | FW |
| Market Cap | 52.66M 5.5M 4.74M 4.46M 4.07M 7.62M 520M 7.64M 20.43M 267M 20.67M 20.22M 859M | P/E 2024 |
-4.07x | P/E 2025 | -1.77x |
|---|---|---|---|---|---|
| Enterprise Value | 49.62M 5.19M 4.46M 4.2M 3.84M 7.18M 490M 7.2M 19.26M 251M 19.48M 19.05M 809M | EV / Sales 2024 |
12.8x | EV / Sales 2025 | 50.9x |
| Free-Float |
8.88% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.86% | ||
| 1 week | -9.95% | ||
| Current month | -5.61% | ||
| 1 month | +129.22% | ||
| 3 months | +108.26% | ||
| 6 months | -4.08% | ||
| Current year | -63.04% |
| 1 week | 0.7 |  | 0.77 |
| 1 month | 0.3 | | 2.47 |
| Current year | 0.21 | | 2.47 |
| 1 year | 0.21 | | 3 |
| 3 years | 0.21 | | 10.5 |
| 5 years | 0.21 | | 42.25 |
| 10 years | 0.21 | | 177 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bengt Jönsson
CEO | Chief Executive Officer | 64 | 2025-11-10 |
Jonas Brisland
DFI | Director of Finance/CFO | - | 2025-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Carl Olsson
BRD | Director/Board Member | 64 | 2022-12-31 |
Bengt Jönsson
CHM | Chairman | 64 | 2023-12-31 |
Tanu Tandan
BRD | Director/Board Member | 67 | 2023-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/10/24 | Buy | 35,000 | 0.0653% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.86% | -9.95% | -71.76% | -81.80% | 5.5M | |
| -0.89% | -1.09% | +19.16% | +67.77% | 48.26B | |
| -1.72% | -1.15% | +45.80% | +117.34% | 40.5B | |
| -2.01% | -5.96% | +10.47% | +76.64% | 11.83B | |
| -0.70% | -2.70% | -10.84% | +11.79% | 11.85B | |
| +2.31% | 0.00% | +26.67% | +153.33% | 9.36B | |
| -1.67% | -0.35% | +41.04% | -11.59% | 7.37B | |
| +0.08% | -4.11% | +24.83% | +43.80% | 7.5B | |
| -0.89% | -3.09% | +18.78% | +207.82% | 7.28B | |
| -0.16% | -2.36% | -46.14% | +16.28% | 5.19B | |
| Average | -0.48% | -2.88% | +5.80% | +60.14% | 14.91B | |
| Weighted average by Cap. | -0.95% | -1.71% | +22.87% | +82.77% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.77M 1.65M 1.42M 1.33M 1.22M 2.28M 156M 2.29M 6.12M 79.84M 6.19M 6.05M 257M | 2.74M 286K 246K 232K 212K 396K 27.03M 397K 1.06M 13.87M 1.08M 1.05M 44.68M |
| Net income | -43.81M -4.58M -3.94M -3.71M -3.39M -6.34M -432M -6.35M -17M -222M -17.19M -16.82M -715M | -75.14M -7.85M -6.76M -6.36M -5.81M -10.87M -742M -10.9M -29.16M -380M -29.49M -28.85M -1.23B |
| Net Debt | -2.08M -218K -188K -176K -161K -302K -20.58M -302K -809K -10.56M -818K -801K -34.01M | -3.04M -317K -273K -257K -235K -439K -29.97M -440K -1.18M -15.38M -1.19M -1.17M -49.54M |
Employees
4
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | SEK 0.7060 | +0.86% | 16,259 |
| 26-09-03 | SEK 0.7000 | 0.00% | 4,999 |
| 26-09-02 | SEK 0.7000 | -5.91% | 40,502 |
| 26-09-01 | SEK 0.7440 | -0.53% | 15,205 |
| 26-08-31 | SEK 0.7480 | -4.59% | 40,916 |
- Stock Market
- Stocks
- ERMA Stock
Select your edition
All financial news and data tailored to specific country editions
